Epididymis. Spermatozoa produced in seminiferous tubules are transported to and stored/mature in the epididymis. Vas deferens transports sperm, seminal vesicle contributes fluid.
Leydig cells. Interstitial (Leydig) cells in the testes synthesize testosterone. Sertoli cells support spermatogenesis.
Seminal vesicle. Seminal vesicles produce the major volume of seminal plasma rich in fructose and prostaglandins; prostate and bulbourethral glands add additional secretions.
Penis. The clitoris and penis develop from the same embryonic tissue and are homologous structures.
Uterus. The blastocyst implants into the endometrium (uterine lining); implantation in tube causes ectopic pregnancy.
Allantois. The allantois contributes to formation of the umbilical vessels and connecting stalk of the umbilical cord; chorion and amnion also contribute to fetal membranes.
Prolactin. Prolactin from anterior pituitary stimulates milk synthesis (lactogenesis); oxytocin mediates milk ejection (let-down).
Microlecithal and non-cleidoic. Mammalian ova have very little yolk (microlecithal) and are not enclosed by a shell (non-cleidoic).
Capacitation. Capacitation (in female reproductive tract) renders sperm capable of fertilizing by membrane changes and hyperactivation. Cortical reaction occurs in the oocyte after sperm entry.
Colostrum. The first secretion is colostrum—rich in proteins, antibodies (especially IgA) and immune factors.
IgA. Colostrum contains high levels of secretory IgA which provides passive mucosal immunity to the newborn.
Sertoli cells. Sertoli cells secrete ABP which binds testosterone in the seminiferous tubules, maintaining high local androgen concentration for spermatogenesis.
Luteal phase is characterized by high progesterone (from corpus luteum) and inhibited FSH/LH; a rise in FSH does not occur in the luteal phase. The other matches are correct.
Both statements true. Testes are located in the scrotum outside the abdominal cavity; the scrotum maintains a temperature about 2°C lower than body temperature which is essential for normal spermatogenesis.
A and R are true, R is the correct explanation of A
A is correct. R is not correct as stated: ovulation occurs at mid-cycle (the ovulatory phase) around the end of the follicular/preovulatory period, and is usually described as a separate ovulatory event rather than occurring throughout the follicular phase.
A is true, R is false
Both statements false. The sperm head contains the nucleus and the acrosome. Mitochondria are located in the mid-piece (neck) arranged helically around the flagellum, not in the acrosome.
Both A and R are false
Spermatogenesis and spermiogenesis are two distinct phases of male gamete formation. Spermatogenesis is the entire process of formation of male gametes from spermatogonial stem cells through a series of mitotic and meiotic divisions. It involves three main stages: mitotic proliferation of spermatogonia to produce primary spermatocytes, the first meiotic division producing secondary spermatocytes, and the second meiotic division producing haploid spermatids. This process takes approximately 74 days in humans and results in the formation of four haploid spermatids from each diploid spermatogonium. Spermiogenesis, in contrast, is the final phase of spermatogenesis involving cytodifferentiation of the haploid spermatids into mature spermatozoa. During spermiogenesis, the spermatid undergoes structural transformations including condensation and elongation of the nucleus, formation of the acrosome from the Golgi apparatus, development of the flagellum for motility, aggregation of mitochondria in the mid-piece to provide energy, and shedding of excess cytoplasm. While spermatogenesis involves cell division and proliferation, spermiogenesis is a process of cellular differentiation and morphological transformation without further cell division.
In the newborn male, germ cells are present as spermatogonial stem cells, also called gonocytes or spermatogonia, which remain mitotically quiescent and dormant until the onset of puberty. These cells are located in the seminiferous tubules of the testes but do not undergo active division or differentiation at birth. Spermatogenesis does not begin until puberty when hormonal stimulation triggers the activation and proliferation of these spermatogonial stem cells. In the newborn female, oocytes are present as primary oocytes that are arrested in the prophase I stage (specifically the dictyate or diplotene stage) of meiosis I. These primary oocytes remain suspended in this arrested state within primordial and primary follicles of the ovary until puberty. Each primary oocyte is surrounded by a single layer of follicle cells and is enclosed within a zona pellucida. The primary oocytes remain in this meiotic arrest until ovulation occurs, when the completion of meiosis I and progression to metaphase II takes place.
a. FSH — Follicle Stimulating Hormone b. LH — Luteinizing Hormone c. hCG — human Chorionic Gonadotropin d. hPL — human Placental Lactogen
Polyspermy, the entry of multiple sperm into an ovum, is prevented in humans primarily through the cortical reaction. When the first sperm fuses with the oocyte membrane, this triggers the cortical reaction, a process in which cortical granules present in the cytoplasm of the oocyte release their contents into the perivitelline space. These granules contain enzymes and other substances that modify the zona pellucida, the glycoprotein layer surrounding the oocyte. Specifically, the enzymes alter the zona pellucida glycoproteins, particularly ZP3 receptors which are responsible for sperm binding, making them unable to bind additional sperm. The zona pellucida also hardens and thickens following the cortical reaction, creating a physical barrier that prevents further sperm penetration. Additionally, changes in the oocyte plasma membrane and the formation of a fertilization membrane contribute to preventing polyspermy. These mechanisms work together to ensure that only one sperm successfully fertilizes the egg, maintaining the correct diploid chromosome number in the resulting zygote.
Colostrum: first postpartum secretion of mammary glands. Significance: provides passive immunity to the newborn (high IgA) protecting mucosal surfaces, supplies concentrated proteins and minerals, acts as a mild laxative helping expel meconium, contains growth factors (EGF) and lactoferrin that aid gut maturation and inhibit pathogens, and helps initiate neonatal nutrition and thermoregulation.
Colostrum is the first milk secreted by the mammary glands immediately after childbirth, typically during the first few days postpartum. It is thick, yellowish in appearance, and differs significantly in composition from mature milk. Colostrum is particularly rich in antibodies, especially secretory immunoglobulin A (IgA), which provides passive immunity to the newborn against various pathogens. It also contains high levels of proteins, including lactoferrin and lysozyme which have antimicrobial properties, vitamins, minerals, and growth factors. The significance of colostrum lies in its crucial role in providing immune protection to the newborn during the vulnerable early postnatal period when the infant's own immune system is still developing. The antibodies in colostrum help protect the infant from infections, particularly in the gastrointestinal tract. Additionally, colostrum aids in the establishment of beneficial gut microbiota and promotes the maturation of the infant's intestinal lining. It also has a mild laxative effect that helps clear meconium from the newborn's intestines, facilitating the passage of fetal waste material.
Justification: trophoblast (syncytiotrophoblast) produces human chorionic gonadotropin (hCG) to maintain corpus luteum early in pregnancy; placenta produces progesterone and estrogens (from maternal and fetal steroid precursors) to maintain endometrium and promote uterine growth; human placental lactogen (hPL) modulates maternal metabolism and mammary gland development; relaxin and peptide hormones influence cervical and pelvic changes. These secretions exert endocrine (systemic) effects on mother and fetus, so the placenta is an endocrine tissue.
The placenta is classified as an endocrine tissue because it synthesizes and secretes multiple hormones that regulate pregnancy and fetal development. The placenta produces human chorionic gonadotropin (hCG), which maintains the corpus luteum during early pregnancy and prevents menstruation. It also secretes progesterone, which maintains the uterine lining and prevents uterine contractions. Estrogens produced by the placenta promote uterine growth and prepare the mammary glands for lactation. Human placental lactogen (hPL) is secreted to regulate maternal metabolism and ensure adequate nutrient supply to the fetus. Additionally, the placenta produces relaxin, which softens the pelvic ligaments and cervix to facilitate childbirth. Through the coordinated secretion of these hormones, the placenta functions as a true endocrine organ, regulating both maternal physiology and fetal development throughout pregnancy.
Sketch description (text labels to substitute diagram): - Head: flattened, contains haploid nucleus; anterior acrosome with hydrolytic enzymes (acrosin) for zona penetration. - Neck: contains centrioles; connects head to tail. - Middle piece: cylindrical, packed with spiral mitochondria that supply ATP for motility. - Principal piece (tail): longest flagellar segment with axoneme (9+2 microtubule arrangement) producing propulsion. - End piece: terminal tapering portion of flagellum. Include plasma membrane enveloping the whole cell.
A human spermatozoan is a highly specialized, motile gamete consisting of several distinct regions. The head contains the acrosome at its anterior tip, which houses enzymes necessary for penetrating the ovum, and the nucleus, which carries the haploid genetic material. The neck region connects the head to the tail and contains the proximal and distal centrioles, which are important for organizing the flagellar apparatus. The middle piece is packed with mitochondria arranged in a helical sheath around the axoneme, providing ATP energy for flagellar movement. The principal piece forms the main length of the flagellum and contains the axoneme surrounded by the fibrous sheath, which provides structural support and enhances motility. The end piece is the terminal portion of the flagellum lacking the fibrous sheath. The entire spermatozoan is enclosed by a plasma membrane derived from the spermatid cell membrane. This streamlined structure is optimized for rapid movement through the female reproductive tract to reach and fertilize the ovum.
Functions: (1) Negative feedback on anterior pituitary to suppress follicle stimulating hormone (FSH) secretion, thereby regulating spermatogenesis and folliculogenesis. (2) In females helps modulate FSH during the menstrual cycle to ensure selection of dominant follicle. (3) Acts locally within gonads to regulate gamete maturation.
Inhibin is a peptide hormone secreted by Sertoli cells in the testes of males and by granulosa cells in the ovarian follicles of females. Its primary function is to provide negative feedback inhibition of follicle-stimulating hormone (FSH) secretion from the anterior pituitary gland. In males, inhibin is produced in response to high levels of spermatogenesis and acts to suppress FSH when sperm production is adequate, thereby regulating the rate of spermatogenesis. In females, inhibin is secreted by granulosa cells of developing follicles during the follicular phase of the menstrual cycle and inhibits FSH secretion, which prevents the recruitment and development of additional follicles and ensures that typically only one dominant follicle matures per cycle. By selectively inhibiting FSH without affecting luteinizing hormone (LH) secretion, inhibin provides a specific regulatory mechanism that fine-tunes gonadal function and maintains reproductive homeostasis in both sexes.
Importance: cooler scrotal environment permits efficient spermatogenesis and sperm maturation; thermoregulatory muscles (cremaster and dartos) adjust testicular position to regulate temperature. Descent of testes during development places them in scrotum; failure to descend (cryptorchidism) impairs fertility and increases risk of malignancy.
The testes are located in the scrotum, which is positioned outside the abdominal cavity, rather than remaining in the abdomen where they develop during fetal life. This external location is of critical importance because it allows the testes to maintain a temperature approximately 2 to 4 degrees Celsius below the core body temperature. This lower temperature is essential for normal spermatogenesis, the process of sperm formation. The seminiferous tubules and developing germ cells are highly sensitive to elevated temperatures, and exposure to temperatures as high as normal body temperature results in impaired meiosis, reduced sperm motility, decreased sperm viability, and ultimately male infertility. The scrotal skin has specialized features including thin epidermis, sparse hair, and abundant sweat glands that facilitate heat dissipation. Additionally, the pampiniform plexus of veins surrounding the testis acts as a countercurrent heat exchanger, cooling arterial blood before it reaches the testis. Thus, the scrotal position is a crucial anatomical adaptation that ensures the optimal thermal environment necessary for continuous and efficient production of functional spermatozoa throughout adult male life.
Composition details: seminal vesicles contribute ~60–70% of volume (fructose—energy for sperm, prostaglandins, fibrinogen), prostate contributes ~20–30% (alkaline fluid, citric acid, proteolytic enzymes including PSA for liquefaction, zinc), testes contribute spermatozoa (2–5%) and epididymal secretions (maturation factors), bulbourethral glands add mucus for lubrication. Semen pH ~7.2–7.7 to neutralize vaginal acidity. Contains hormones, nutrients and cofactors essential for sperm motility and survival.
Semen = spermatozoa + seminal plasma (fluid from seminal vesicles, prostate and bulbourethral glands). Major components: sperm cells, fructose, prostaglandins, fibrinogen, alkaline fluid, citric acid, enzymes (prostate-specific antigen), zinc, mucus and buffers.
Detailed sequence: 1. Capacitation: sperm undergo biochemical changes in the female reproductive tract to become capable of fertilization (membrane changes, hyperactivation). 2. Transit to ampulla: sperm reach the ampullary region of the oviduct where the secondary oocyte is present. 3. Acrosome reaction: on contact with zona pellucida (ZP), acrosomal enzymes are released to digest ZP glycoproteins (ZP3 mediates binding), allowing one or few sperm to pass. 4. Penetration: sperm traverse corona radiata and zona pellucida to reach oolemma and bind to receptors; membranes fuse and the sperm nucleus enters the oocyte. 5. Cortical reaction: cortical granules in oocyte release contents that modify the zona pellucida to block polyspermy (zona reaction). 6. Completion of oocyte meiosis: the secondary oocyte completes meiosis II producing the ovum and a second polar body. 7. Pronuclear formation and syngamy: male and female pronuclei form, migrate together, and their chromosomes unite to form a diploid zygote. 8. Cleavage and blastocyst formation: zygote divides to form morula then blastocyst (inner cell mass and trophoblast). 9. Hatching: blastocyst breaks free from zona pellucida. 10. Implantation: about 6–7 days post-fertilization the blastocyst adheres to the receptive endometrium; trophoblast differentiates into cytotrophoblast and syncytiotrophoblast, which invades the endometrium. Endometrium undergoes decidual reaction; syncytiotrophoblast contributes to early placentation and secretion of hCG to maintain corpus luteum. This establishes maternal–fetal interface.
Fertilization is the fusion of male and female gametes to form a diploid zygote and occurs in the ampulla of the fallopian tube. The process begins with capacitation, during which spermatozoa undergo biochemical changes in the female reproductive tract that enhance their fertilizing ability. As the sperm approaches the ovum, the acrosome reaction occurs, in which enzymes from the acrosome are released to digest the corona radiata and the zona pellucida, the protective layers surrounding the oocyte. The sperm penetrates these barriers and fuses with the oocyte plasma membrane. Upon sperm entry, the cortical reaction is triggered, in which cortical granules release their contents to harden the zona pellucida and prevent polyspermy, ensuring that only one sperm fertilizes the ovum. The sperm nucleus decondenses to form the male pronucleus while the oocyte completes meiosis II to form the female pronucleus. Syngamy, the fusion of male and female pronuclei, restores the diploid chromosome number and establishes the zygote. Following fertilization, the zygote undergoes cleavage divisions as it travels through the fallopian tube, forming a morula and then a blastocyst by the time it reaches the uterus approximately 6 to 7 days after fertilization. The blastocyst hatches from the zona pellucida and undergoes implantation, during which the trophoblast cells adhere to the receptive endometrium of the uterus. The trophoblast then invades the endometrium, with the outer cells differentiating into syncytiotrophoblast that erodes maternal blood vessels and establishes the early placental connection. This process anchors the embryo in the uterus and initiates the exchange of nutrients, gases, and wastes between the mother and developing embryo.
Definition expanded: involves proliferation of primordial germ cells to spermatogonia or oogonia, meiotic divisions (reduction division) producing haploid cells, and spermiogenesis or oocyte maturation to produce functional spermatozoa or ova. Includes spermatogenesis in testes and oogenesis in ovaries.
Gametogenesis is the biological process by which haploid gametes, namely spermatozoa in males and ova in females, are produced from diploid germ cells located in the gonads. The process involves three main components: mitosis, which increases the number of germ cells; meiosis, which reduces the chromosome number from diploid to haploid; and differentiation, which transforms the products of meiosis into functional, specialized gametes. In males, spermatogenesis occurs continuously in the seminiferous tubules of the testes from puberty throughout adult life, producing millions of motile sperm daily. In females, oogenesis begins during fetal development, arrests in prophase I of meiosis I, and resumes cyclically during the menstrual cycle from menarche to menopause, typically producing one mature ovum per cycle. Both processes are regulated by gonadotropic hormones, follicle-stimulating hormone (FSH) and luteinizing hormone (LH), which are secreted by the anterior pituitary gland. Gametogenesis is essential for sexual reproduction, as it generates the genetic diversity necessary for offspring and ensures the transmission of genetic material from parents to the next generation.
Textual labelled description to substitute diagram: - Corona radiata: several layers of follicle cells surrounding the zona; provide nutrients and support. - Zona pellucida: acellular glycoprotein layer (ZP1, ZP2, ZP3) that mediates sperm binding and prevents polyspermy after fertilization. - Oolemma (vitelline membrane): plasma membrane of the oocyte. - Ooplasm: cytoplasm rich in yolk granules, ribosomes, mitochondria, and maternal mRNAs and proteins needed for early development. - Nucleus: haploid oocyte nucleus (germinal vesicle in arrested prophase I or female pronucleus after fertilization). - Cortical granules: just beneath oolemma; release contents during cortical reaction to modify zona pellucida. - Polar body: small cell produced during unequal meiotic divisions, contains discarded chromosomes. (Human ovum diameter ~100–120 µm).
Key structural features/labels of human ovum: corona radiata (outer follicular cells), zona pellucida (glycoprotein layer), oolemma (oocyte plasma membrane), ooplasm (cytoplasm), haploid nucleus (female pronucleus when formed), cortical granules, polar body.
Schematic notes: Spermatogenesis occurs continuously from puberty in seminiferous tubules; involves Sertoli cell support and yields many motile sperm. Oogenesis begins prenatally: primary oocytes arrested in prophase I until puberty; one primary oocyte completes meiosis I monthly producing a large secondary oocyte (arrested at metaphase II) which is ovulated; only on fertilization does meiosis II complete to form a functional ovum; results in one ovum and polar bodies (unequal cytokinesis).
Spermatogenesis: Spermatogonium (2n) → (mitosis) primary spermatocyte (2n) → (meiosis I) two secondary spermatocytes (n) → (meiosis II) four spermatids (n) → (spermiogenesis) four spermatozoa. Oogenesis: Oogonium (2n) → (mitosis) primary oocyte (2n, arrested prophase I) → (meiosis I at ovulation) secondary oocyte (n) + first polar body → (meiosis II at fertilization) ovum (n) + second polar body.
Detailed explanation: 1. Menstrual phase (days 1–4/5): decline of progesterone and estrogen (if no pregnancy) causes spiral artery constriction, necrosis and shedding of functional layer of endometrium — menstrual bleeding. FSH levels begin to rise, stimulating follicular growth. 2. Proliferative (follicular) phase (days 5–14): rising FSH promotes development of ovarian follicles and estradiol (estrogen) secretion by growing follicles. Estrogen stimulates regeneration and proliferation of endometrium (thickening, formation of glands and vascularization). A dominant follicle (Graafian follicle) emerges. High estrogen exerts positive feedback late in the follicular phase, leading to LH surge. 3. Ovulation (around day 14): LH surge triggers rupture of Graafian follicle and release of the secondary oocyte arrested in metaphase II. Estrogen level peaks just before ovulation. 4. Secretory (luteal) phase (days 15–28): after ovulation the ruptured follicle becomes corpus luteum which secretes progesterone (and some estrogen). Progesterone transforms the endometrium into a secretory state: glands become coiled and secrete nutrient-rich fluid, endometrium becomes receptive for implantation. If fertilization does not occur, corpus luteum degenerates to corpus albicans, progesterone and estrogen fall causing menstruation to start again. Hormonal regulation: FSH and LH from anterior pituitary (regulated by GnRH) control ovarian events; estrogen and progesterone exert feedback on pituitary and hypothalamus.
The menstrual cycle is a monthly reproductive cycle in females that typically lasts 28 days and consists of four distinct phases coordinated by hormonal fluctuations. The menstrual phase, occurring on days 1 to 5, is characterized by shedding of the endometrial lining, resulting in bleeding that lasts 3 to 5 days. During this phase, levels of estrogen and progesterone are low, which triggers the release of FSH from the anterior pituitary. The proliferative or follicular phase, spanning days 6 to 14, is marked by rising FSH levels that stimulate the growth and maturation of ovarian follicles and increased secretion of estrogen by granulosa cells. Estrogen promotes proliferation and thickening of the endometrium in preparation for implantation. The surge in estrogen levels triggers a positive feedback effect on the anterior pituitary, causing a sharp surge in LH secretion. Ovulation occurs around day 14 when the LH surge triggers the release of the secondary oocyte from the mature Graafian follicle. The secretory or luteal phase, extending from day 15 to day 28, begins after ovulation when the remnants of the ovarian follicle transform into the corpus luteum under the influence of LH. The corpus luteum secretes progesterone and some estrogen, which maintain and further prepare the endometrium for implantation. If fertilization does not occur, the corpus luteum degenerates after approximately 14 days, progesterone and estrogen levels decline sharply, and this hormonal withdrawal triggers menstruation, initiating a new cycle. These coordinated hormonal and ovarian changes ensure the cyclical preparation of the uterus for potential pregnancy.
Roles in detail: Oxytocin is released in response to cervical stretch and suckling; during labor it increases strength and frequency of uterine contractions (positive feedback loop: stretch → oxytocin → stronger contractions → more stretch). During lactation, oxytocin causes contraction of myoepithelial cells in mammary alveoli and ducts, resulting in milk ejection. Relaxin (placental and ovarian) increases flexibility of the pubic symphysis and cervix by remodeling connective tissue, aiding passage of the fetus through the birth canal and enabling cervical dilation. Relaxin may also modulate uterine contractility and blood flow to the placenta.
Oxytocin: from posterior pituitary stimulates uterine contractions (parturition) via positive feedback and causes milk ejection (let-down) by contracting myoepithelial cells around alveoli. Relaxin: from corpus luteum and placenta softens cervix and relaxes pubic symphysis/ligaments facilitating parturition.
Reconstructed question: "Identify the given image (female reproductive system) and label parts a, b, c and d." Labels and brief functions: a: Ovary — produces ova and ovarian hormones (estrogen, progesterone); b: Fallopian tube/oviduct (ampulla) — site of fertilization and transport of ovum; c: Uterus (body) — site of implantation and fetal development; d: Cervix — lower uterine segment that opens into vagina, acts as barrier and dilates during childbirth. (Note: image was not provided; labels are assigned to the most likely textbook figure.)
The image depicts a schematic diagram of the human female reproductive tract, showing the internal and external reproductive organs. Part a represents the ovary, the paired gonadal organ located on either side of the uterus that produces oocytes and secretes estrogen and progesterone. Part b indicates the fallopian tube, also called the oviduct, which is a muscular tube extending from the ovary toward the uterus; the region shown is typically the ampulla, the widest and most dilated portion where fertilization usually occurs. Part c represents the uterus or womb, specifically the body or fundus, which is the main muscular chamber where the fertilized ovum implants and the embryo develops during pregnancy. Part d indicates the cervix, the narrow, cylindrical lower portion of the uterus that opens into the vagina; the cervix contains mucus-secreting glands and acts as a barrier between the uterus and the external environment. Together, these structures form the pathway through which the oocyte travels after ovulation, where fertilization may occur, and where the developing embryo implants and grows.
a) Ovulation is shown by the ruptured Graafian follicle releasing the secondary oocyte; stage = secondary oocyte (metaphase II). b) Hormones: Rising estradiol from the follicle causes positive feedback leading to an LH surge from anterior pituitary; LH surge triggers ovulation. c) Simultaneous uterine events: under prior estrogen the endometrium has proliferated; after ovulation progesterone from corpus luteum induces secretory changes — glands enlarge and secrete glycogen-rich fluid, stroma becomes edematous and highly vascular to receive an embryo. d) C vs H (assumption): C (corpus luteum) — endocrine, produces progesterone, supports early pregnancy; H (corpus albicans) — degenerated corpus luteum, connective-tissue scar, no hormone secretion.
a) The figure showing the ruptured mature (Graafian) follicle illustrates ovulation; it represents release of a secondary oocyte arrested in metaphase II. b) Ovarian hormone: estrogen (produced by the mature follicle); Pituitary hormone: LH (luteinizing hormone surge). c) Uterine changes: endometrium moves from proliferative to secretory phase under progesterone (after corpus luteum forms): becomes thicker, more glandular and vascularized; glands secrete nutrient-rich fluid preparing for implantation. d) Difference between C and H (assumed C = corpus luteum; H = corpus albicans): corpus luteum is yellow, functional, secretes progesterone and some estrogen; corpus albicans is a pale fibrous scar (degenerate corpus luteum), non-functional and hormone-inactive.